Investigator-initiated Trials (IITs) are an integral and increasingly important part of the clinical research landscape. In this article, John Denier at Clinigen disc...

Modern patients are taking control of their own healthcare, from sharing information with one another to approaching industry organisations with their concerns. Tarqu...

A revolution is happening in the healthcare industry. Societal pressure to improve our health, technological advances, and market forces are all driving forward a nov...

Integration and increased automation are transforming the way life sciences companies manage much of their operational and regulatory information. Labelling and packa...

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the...

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge at PAREXEL ...

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, Tati...

Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. Kelechi K. Olu MD, MSc, Vijayanand Rajen...

The biopharmaceutical industry invests billions of dollars annually into clinical research to address a range of debilitating respiratory conditions. Phil Lake at ERT...

There are currently a number of pharmaceutical or device-based heart failure therapies in clinical use, with numerous promising candidates under development. Bobby St...